IDEXX Laboratories Inc (IDXX)
418.55
-0.06
(-0.01%)
USD |
NASDAQ |
Nov 21, 16:00
428.99
+10.44
(+2.49%)
After-Hours: 05:09
IDEXX Laboratories Debt to Equity Ratio: 0.5401 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.5401 |
| June 30, 2024 | 0.5979 |
| March 31, 2024 | 0.6028 |
| December 31, 2023 | 0.6385 |
| September 30, 2023 | 0.7853 |
| June 30, 2023 | 0.947 |
| March 31, 2023 | 1.430 |
| December 31, 2022 | 2.215 |
| September 30, 2022 | 2.928 |
| June 30, 2022 | 3.017 |
| March 31, 2022 | 1.834 |
| December 31, 2021 | 1.339 |
| September 30, 2021 | 1.130 |
| June 30, 2021 | 1.211 |
| March 31, 2021 | 1.286 |
| December 31, 2020 | 1.437 |
| September 30, 2020 | 2.050 |
| June 30, 2020 | 3.741 |
| March 31, 2020 | 11.00 |
| December 31, 2019 | 5.565 |
| September 30, 2019 | 4.575 |
| June 30, 2019 | 5.560 |
| March 31, 2019 | 20.29 |
| December 31, 2018 | -105.15 |
| September 30, 2018 | -633.99 |
| Date | Value |
|---|---|
| June 30, 2018 | -25.29 |
| March 31, 2018 | -20.63 |
| December 31, 2017 | -23.31 |
| September 30, 2017 | -26.54 |
| June 30, 2017 | -15.11 |
| March 31, 2017 | -17.09 |
| December 31, 2016 | -11.11 |
| September 30, 2016 | 19.82 |
| June 30, 2016 | -133.82 |
| March 31, 2016 | -16.53 |
| December 31, 2015 | -13.91 |
| September 30, 2015 | -29.36 |
| June 30, 2015 | 129.54 |
| March 31, 2015 | 30.85 |
| December 31, 2014 | 7.65 |
| September 30, 2014 | 3.161 |
| June 30, 2014 | 1.179 |
| March 31, 2014 | 0.91 |
| December 31, 2013 | 0.8267 |
| September 30, 2013 | 0.7457 |
| June 30, 2013 | 0.6724 |
| March 31, 2013 | 0.4155 |
| December 31, 2012 | 0.3371 |
| September 30, 2012 | 0.3801 |
| June 30, 2012 | 0.4186 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5401
Minimum
Sep 2024
11.00
Maximum
Mar 2020
2.215
Average
1.384
Median
Debt to Equity Ratio Benchmarks
| Agilent Technologies Inc | 0.4967 |
| Bio-Rad Laboratories Inc | 0.1604 |
| Regeneron Pharmaceuticals Inc | 0.0677 |
| West Pharmaceutical Services Inc | 0.0736 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.351B |
| Total Liabilities (Quarterly) | 1.733B |
| Shareholders Equity (Quarterly) | 1.618B |
| Current Ratio | 1.421 |
| Net Debt Paydown Yield | 0.08% |